Prime Medicine PRME
NASDAQ PRME
$3.68 -0.03 (-0.67%)
As of: Sep 4, 2026 · 3:15 PM EDT

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Prime Medicine's (PRME) quarterly Preferred Dividend Payments came in at $1.3 million in Q4 2022, down 79.35% on a QoQ basis from $6.4 million in Q3 2022.

Analysis

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022) Analysis & Trends

Prime Medicine (PRME) has 2 years of Preferred Dividend Payments data on file, last reported at $1.3 million in Q4 2022.

  • Quarterly Preferred Dividend Payments changed N/A year-over-year to $1.3 million in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $1.3 million (down 93.04% YoY) and the FY2022 annual result came in at $20.2 million, up 1275.54% from the prior year.
  • Preferred Dividend Payments retreated to $1.3 million in Q4 2022, from $6.4 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $6.4 million in Q3 2021 to a low of $1.3 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
10 Prime Medicine 653.07 Mn 653.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.31 Mn
Sep 30, 2022 6.36 Mn
Jun 30, 2022 6.29 Mn
Mar 31, 2022 6.22 Mn
Dec 31, 2021 6.36 Mn
Sep 30, 2021 6.36 Mn